Details
🚨 New Cardio Town Hall: Expert Perspectives on Contemporary ATTR-CM Clinical Research
The treatment landscape for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) continues to evolve.
Join leading experts as they discuss recent clinical trials, emerging therapies, and liver-targeted treatment strategies designed to reduce transthyretin production—and what these developments could mean for patient care.
💻 Register today and stay up to date on the latest advances in ATTR-CM.